Benzodiazepines Deprescribing in Nursing Homes: Intervention Feasibility
END-IT NH
Feasibility of a Theory-based Benzodiazepines Deprescribing Intervention in Belgian Nursing Homes: the END-IT Study
1 other identifier
interventional
80
1 country
1
Brief Summary
The goal of this feasibility study is to evaluate the feasibility of a complex intervention towards benzodiazepines and Z-drugs deprescribing in older adults living in the Belgian nursing home setting. The main questions it aims to answer are:
- Is the intervention we developped feasible
- To what extent will the intervention be implemented in nursing homes
- To what extent is the design of the recruitment and data collection process feasible and acceptable for all participants Participants will benefit from a complex intervention implemented at the level of the nursing home, encompassing process and goals setting, healthcare providers education, environmental adaptations, audit and feedback on benzodiazepines use, use of educational leaflet with residents and relatives, and multidisciplinary work. Researchers will compare this intervention to usual care, to see if the intervention is feasible, and to gather first data on intervention effectiveness in benzodiazepines deprescriping.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 23, 2023
CompletedStudy Start
First participant enrolled
June 22, 2023
CompletedFirst Posted
Study publicly available on registry
July 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedJuly 3, 2023
June 1, 2023
6 months
May 23, 2023
June 26, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Nursing homes' adherence to the intervention
has the intervention been implemented as intended, e.g. global number of implemented intervention components
Assessed at 6 months
Healthcare providers responsiveness to the intervention
has far did they respond to the intervention, and how far have them been engaged by the intervention, e.g level of attendance to education session for healthcare providers
Assessed at 6 months
nursing home residents' responsiveness to the intervention
has far did they respond to the intervention, and how far have them been engaged by the intervention
Assessed at 6 months
Feasibility of the recruitment process
The feasibility of the recruitment will be assessed through the ratio between included residents and residents contacted for participation.
At 6 months
Feasibility of the data collection process
Data collection process will be assessed through the quality of collected data (rate of missing data)
At 6 months
Secondary Outcomes (7)
Contextual factors at the level of of the nursing home
Baseline
Contextual factors at the level of the nursing home resident
Baseline
Intervention mechanisms of impact
At baseline
Intervention mechanisms of impact
At 3 months
Intervention mechanisms of impact
At 6 months
- +2 more secondary outcomes
Study Arms (2)
END-IT intervention for nursing homes
EXPERIMENTALThis complex intervention, implemented at the level of the nursing home, encompasses process and goals setting, education for healthcare providers, environmental adaptations, audit and feedback on benzodiazepine use, use of an educational leaflet for residents and relatives, and multidisciplinary work.
Control
NO INTERVENTIONUsual care. Nursing homes allocated to this study arm will access intervention material at the end of the study.
Interventions
Complex intervention, as described in the arm/group descriptions
Eligibility Criteria
You may qualify if:
- years old and older
- Taking at least one benzodiazepine or Z-drug for 4 weeks or more
You may not qualify if:
- Unability to communicate in French
- Palliative care
- Ongoing benzodiazepine withdrawal
- Ongoing alcohol withdrawal
- Severe anxiety
- Severe depression
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Université Catholique de Louvainlead
- EBPracticenetcollaborator
- Fonds National de la Recherche scientifique (FNRS)collaborator
Study Sites (1)
UCLouvain
Woluwe-Saint-Lambert, 1200, Belgium
Related Publications (1)
Evrard P, Chevallereau T, Aikpitanyi J, Petein C, Tubeuf S, Henrard S, Spinewine A. Feasibility of a theory-based intervention towards benzodiazepine deprescribing in Belgian nursing homes: protocol of the END-IT NH cluster-randomised controlled trial. BMJ Open. 2024 Oct 22;14(10):e085435. doi: 10.1136/bmjopen-2024-085435.
PMID: 39438099DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anne Spinewine, PhD
UCLouvain / Louvain Drug Research Institute / Clinical pharmacy research group
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 23, 2023
First Posted
July 3, 2023
Study Start
June 22, 2023
Primary Completion
January 1, 2024
Study Completion
June 1, 2024
Last Updated
July 3, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share
Only publishable project data relating to the main analysis and research output will be shared on a data repository after an embargo period of two years after June 2024. All relevant documentation necessary to facilitate data re-use will be shared along with the datasets.